Cargando…
Seroprevalence of Wenzhou virus in China
Wenzhou virus (WENV) was first identified in rodents and Asian house shrews in Wenzhou, Zhejiang Province, China. However, little is known about the prevalence of WENV infections in humans in China. To determine the threat that WENV may pose to humans, we determine the seroprevalence of WENV in heal...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Medical Association Publishing House. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361105/ https://www.ncbi.nlm.nih.gov/pubmed/32838285 http://dx.doi.org/10.1016/j.bsheal.2020.07.004 |
_version_ | 1783559344148709376 |
---|---|
author | Guo, Li Liu, Shasha Song, Jingdong Han, Lianlian Zhang, Hu Wu, Chao Wang, Conghui Zhou, Hongli Wang, Jianwei |
author_facet | Guo, Li Liu, Shasha Song, Jingdong Han, Lianlian Zhang, Hu Wu, Chao Wang, Conghui Zhou, Hongli Wang, Jianwei |
author_sort | Guo, Li |
collection | PubMed |
description | Wenzhou virus (WENV) was first identified in rodents and Asian house shrews in Wenzhou, Zhejiang Province, China. However, little is known about the prevalence of WENV infections in humans in China. To determine the threat that WENV may pose to humans, we determine the seroprevalence of WENV in healthy individuals in China in this study. Cross-reactivities of nucleoprotein (NP) were detected between Lymphocytic choriomeningitis virus (LCMV) and WENV using Western blot and ELISA assy. The prevalence of specific IgG antibodies against WENV NP was investigated in different age groups of 830 healthy individuals aged 0–70 years old in China using a competition ELISA assay. The results indicate that WENV and LCMV share cross-reactive epitopes between NPs. The total seroprevalence of WENV in healthy adults was 4.6%, with 3.6% (8/221) for individuals 15–44 years of age, 5.4% (17/317) for individuals 45–59 years of age, and 4.1% (4/98) for older adults over 60. The total seroprevalence of WENV in children under age 15 was 1.5%, with 2.9% (1/34) in children aged 2–5 years, and 2.2% in 5–14 years (2/91). The finding suggests that WENV or WENV-like virus may sporadically infect humans of China. |
format | Online Article Text |
id | pubmed-7361105 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Chinese Medical Association Publishing House. Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73611052020-07-15 Seroprevalence of Wenzhou virus in China Guo, Li Liu, Shasha Song, Jingdong Han, Lianlian Zhang, Hu Wu, Chao Wang, Conghui Zhou, Hongli Wang, Jianwei Biosaf Health Article Wenzhou virus (WENV) was first identified in rodents and Asian house shrews in Wenzhou, Zhejiang Province, China. However, little is known about the prevalence of WENV infections in humans in China. To determine the threat that WENV may pose to humans, we determine the seroprevalence of WENV in healthy individuals in China in this study. Cross-reactivities of nucleoprotein (NP) were detected between Lymphocytic choriomeningitis virus (LCMV) and WENV using Western blot and ELISA assy. The prevalence of specific IgG antibodies against WENV NP was investigated in different age groups of 830 healthy individuals aged 0–70 years old in China using a competition ELISA assay. The results indicate that WENV and LCMV share cross-reactive epitopes between NPs. The total seroprevalence of WENV in healthy adults was 4.6%, with 3.6% (8/221) for individuals 15–44 years of age, 5.4% (17/317) for individuals 45–59 years of age, and 4.1% (4/98) for older adults over 60. The total seroprevalence of WENV in children under age 15 was 1.5%, with 2.9% (1/34) in children aged 2–5 years, and 2.2% in 5–14 years (2/91). The finding suggests that WENV or WENV-like virus may sporadically infect humans of China. Chinese Medical Association Publishing House. Published by Elsevier B.V. 2020-09 2020-07-15 /pmc/articles/PMC7361105/ /pubmed/32838285 http://dx.doi.org/10.1016/j.bsheal.2020.07.004 Text en © 2020 Chinese Medical Association Publishing House. Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Guo, Li Liu, Shasha Song, Jingdong Han, Lianlian Zhang, Hu Wu, Chao Wang, Conghui Zhou, Hongli Wang, Jianwei Seroprevalence of Wenzhou virus in China |
title | Seroprevalence of Wenzhou virus in China |
title_full | Seroprevalence of Wenzhou virus in China |
title_fullStr | Seroprevalence of Wenzhou virus in China |
title_full_unstemmed | Seroprevalence of Wenzhou virus in China |
title_short | Seroprevalence of Wenzhou virus in China |
title_sort | seroprevalence of wenzhou virus in china |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361105/ https://www.ncbi.nlm.nih.gov/pubmed/32838285 http://dx.doi.org/10.1016/j.bsheal.2020.07.004 |
work_keys_str_mv | AT guoli seroprevalenceofwenzhouvirusinchina AT liushasha seroprevalenceofwenzhouvirusinchina AT songjingdong seroprevalenceofwenzhouvirusinchina AT hanlianlian seroprevalenceofwenzhouvirusinchina AT zhanghu seroprevalenceofwenzhouvirusinchina AT wuchao seroprevalenceofwenzhouvirusinchina AT wangconghui seroprevalenceofwenzhouvirusinchina AT zhouhongli seroprevalenceofwenzhouvirusinchina AT wangjianwei seroprevalenceofwenzhouvirusinchina |